Skip to main content
. 2014 Oct 27;111(45):E4869–E4877. doi: 10.1073/pnas.1403438111

Table 1.

Antiproliferative activity of FGFR inhibitors on transformed Ba/F3 cells

Ba/F3 cell lines EC50, nM
FIIN-1 BGJ398 FIIN-2 FIIN-3 FRIN-2 FRIN-3
Parental >3,300 >3,300 >3,300 2,970 >3,300 >3,300
FGFR1 14 3 4 1
FGFR2 7 4 1 <1 10 3
FGFR2 (V564M) 1,000 1,500 58 64 2,810 1,380
FGFR2 (V564F) >3,300 3,145 100 71
FGFR2 (E565K) >3,300 490 273 69
FGFR2 (K659N) 3,710 25 9 6
FGFR2 (M538I) 839 43 27 30
FGFR2 (C491A) 168 1 8 3 195 26
FGFR2(C491A/V564M) >3,300 2,100 3,140 1,000
FGFR3 (S249C) 10 67 93 41
FGFR4 >1,000 >1,000 32 22 >1,000 >1,000
EGFR (VIII) >3,300 >3,300 506 135 >3,300 1,840
EGFR (L858R) >3,300 >3,300 231 16.8 2,590 2,538
EGFR DEL(E746-A750) 240
EGFR (T790M/L858R) >3,300 >3,300 1,773 231 >3,300 >3,300
EGFR (DEL/T790M) 687
EGFR (C797S/L858R) >3,300 >3,300 >3,300
HHS Vulnerability Disclosure